Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO)
Condition(s) studied
Investigational drug(s) / intervention(s)
Luminotherapy and /or Psychoeducation Program: TO complete
Study summary
Bipolar disorder affects more than 1% of the population. This pathology is considered as one of the most serious psychiatric disorder because of it is high suicide rates. It impacts patients life quality on many aspects, and specially their sleeping and circadian Rhythms. This can lead to more severe symptoms up to for thymic relapses. It was shown that Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.
Eligibility
Primary outcome measure(s)
- Number of days in-hospital — Day 0 to Day 365
Number of days patients spent in the hospital
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier Henri Laborit | Poitiers | France | Recruiting |
More Centre Hospitalier Henri Laborit trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04917419 on ClinicalTrials.gov ↗ ← All trials in France